Investigation of interaction between CPT-11 and bilirubin

被引:0
|
作者
Kato, Ryuji [1 ]
Sadamatsu, Maiko [1 ]
Nishide, Mami [1 ]
Marikawa, Risa [1 ]
Sasaki, Daisuke [1 ]
Kadobayashi, Takaaki [1 ]
Kobayashi, Toyohide [2 ]
Urashima, Kazuya [2 ]
Ijiri, Yoshio [1 ]
Tanaka, Kazuhiko [1 ]
机构
[1] Osaka Univ Pharmaceut Sci, Lab Clin Pharm & Clin Pharmacokinet, Takatsuki, Osaka 5691094, Japan
[2] Osaka Med Coll Hosp, Dept Pharm, Takatsuki, Osaka 5698686, Japan
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2008年 / 128卷
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:49 / 49
页数:1
相关论文
共 50 条
  • [1] PHARMACOLOGICAL CORRELATION BETWEEN TOTAL DRUG CONCENTRATION AND LACTONES OF CPT-11 AND SN-38 IN PATIENTS TREATED WITH CPT-11
    SASAKI, Y
    YOSHIDA, Y
    SUDOH, K
    HAKUSUI, H
    FUJII, H
    OHTSU, T
    WAKITA, H
    IGARASHI, T
    ITOH, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (01): : 111 - 116
  • [2] CPT-11 in gastrointestinal cancer
    Bleiberg, H
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) : 371 - 379
  • [3] CPT-11 - The European experience
    Armand, JP
    Terret, C
    Couteau, C
    Rixe, O
    CAMPTOTHECINS: FROM DISCOVERY TO THE PATIENT, 1996, 803 : 282 - 291
  • [4] The interaction of buthionine sulphoximide (BSO) and the topoisomerase I inhibitor CPT-11
    Sawyer, TE
    Bonner, JA
    BRITISH JOURNAL OF CANCER, 1996, 74 : S109 - S113
  • [5] Pre-treatment serum total bilirubin level as an indicator of optimal CPT-11 dosage
    Makihara, Katsuya
    Azuma, Sayaka
    Kawato, Nobuyuki
    Ueno, Hiroyuki
    Nakata, Izumi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 273 - 279
  • [6] Pre-treatment serum total bilirubin level as an indicator of optimal CPT-11 dosage
    Katsuya Makihara
    Sayaka Azuma
    Nobuyuki Kawato
    Hiroyuki Ueno
    Izumi Nakata
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 273 - 279
  • [7] Metabolism of CPT-11 - Impact on activity
    Rivory, LP
    CAMPTOTHECINS: UNFOLDING THEIR ANTICANER POTENTIAL, 2000, 922 : 205 - 215
  • [8] NONLINEAR PHARMACOKINETICS OF CPT-11 IN RATS
    KANEDA, N
    YOKOKURA, T
    CANCER RESEARCH, 1990, 50 (06) : 1721 - 1725
  • [9] Pharmacokinetics of CPT-11 in rhesus monkeys
    Inaba M.
    Ohnishi Y.
    Ishii H.
    Tanioka Y.
    Yoshida Y.
    Sudoh K.
    Hakusui H.
    Mizuno N.
    Ito K.
    Sugiyama Y.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (2) : 103 - 108
  • [10] Irinotecan (CPT-11) for multiple myeloma
    Yano, H.
    Iida, S.
    Kayukawa, S.
    Nakagawa, C.
    Oguri, T.
    Ri, M.
    Inagaki, A.
    Sanda, T.
    Kusumoto, S.
    Ishida, T.
    Komatsu, H.
    Suzuki, A.
    Ueda, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 140 - 140